Takeda Pharmaceuticals USA Reports Data Breach to Texas AG

Takeda Pharmaceuticals USA, Inc. has officially reported a data security incident to the Texas Attorney General's office. This filing, made on June 26, 2026, concerns an event that occurred on February 9, 2026. Takeda, a global research-based pharmaceutical company, is currently investigating the scope and impact of this breach.

While the specific types of personal information affected in this incident are not detailed in the public filing, Takeda’s notification indicates that certain data may have been exposed. Individuals who receive a direct notification letter from Takeda should review it closely for particulars relevant to their situation.

Receiving such a notification means your personal information was potentially involved. It is important to understand what Takeda's letter states regarding the incident and any identity protection services they may be offering. These services can help monitor for potential misuse of your data.

As a general precaution following any data security event, individuals should remain vigilant for suspicious activity. This includes regularly checking financial account statements and credit reports for unauthorized transactions or accounts. It is also wise to be cautious of unsolicited communications that request personal details.

This report to the Texas Attorney General is a mandatory disclosure, providing public record of the security incident. Takeda Pharmaceuticals USA, Inc. continues its investigation into the circumstances of the breach to ensure affected individuals are informed and appropriate measures are taken.